The DarT/DarG Toxin–Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies by Giuliana Catara, Rocco Caggiano, Luca Palazzo

Get full text

Mono(ADP-ribosyl)ation Enzymes and NAD⁺ Metabolism: A Focus on Diseases and Therapeutic Perspectives by Palmiro Poltronieri, Angela Celetti, Luca Palazzo

Get full text

ADP-ribosylation signalling and human disease by Luca Palazzo, Petra Mikolčević, Andreja Mikoč, Ivan Ahel

Get full text

Role for non-proteolytic control of M-phase-promoting factor activity at M-phase exit. by Vincenzo D'Angiolella, Luca Palazzo, Concetta Santarpia, Vincenzo Costanzo, Domenico Grieco

Get full text

Serine is the major residue for ADP-ribosylation upon DNA damage by Luca Palazzo, Orsolya Leidecker, Evgeniia Prokhorova, Helen Dauben, Ivan Matic, Ivan Ahel

Get full text

Serine ADP-ribosylation reversal by the hydrolase ARH3 by Pietro Fontana, Juan José Bonfiglio, Luca Palazzo, Edward Bartlett, Ivan Matic, Ivan Ahel

Get full text

CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC by Francesco Morra, Francesco Merolla, Ida Picardi, Daniela Russo, Gennaro Ilardi, Silvia Varricchio, Federica Liotti, Roberto Pacelli, Luca Palazzo, Massimo Mascolo, Angela Celetti, Stefania Staibano

Get full text

The disruption of the CCDC6 – PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma by Francesco Morra, Francesco Merolla, Giovanna Damia, Francesca Ricci, Silvia Varricchio, Gennaro Ilardi, Laura Arenare, Daniela Califano, Virginia Napolitano, Robert Fruscio, Rosa Marina Melillo, Luca Palazzo, Angela Celetti

Get full text